Zhonghong Pulin Medical Products Co., Ltd. (300981.SZ)
CNY 11.83
(-0.34%)
CNY 11.83
(-0.34%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 86.58 Million CNY | -91.13% |
| 2022 | 202.54 Million CNY | -90.01% |
| 2021 | 2.86 Billion CNY | -9.72% |
| 2020 | 3.32 Billion CNY | 1149.32% |
| 2019 | 170.85 Million CNY | 47.05% |
| 2018 | 118.25 Million CNY | 5.53% |
| 2017 | 130.11 Million CNY | 146.11% |
| 2016 | 68.22 Million CNY | -17.02% |
| 2015 | 67.49 Million CNY | 22.74% |
| 2014 | 67.33 Million CNY | 43.89% |
| 2013 | 43.7 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 39.11 Million CNY | 300.74% |
| 2024 Q1 | 27.39 Million CNY | 108.69% |
| 2024 Q3 | 28.08 Million CNY | -32.62% |
| 2023 Q3 | 24.29 Million CNY | -62.52% |
| 2023 FY | - CNY | -91.13% |
| 2023 Q2 | 64.82 Million CNY | 1605.24% |
| 2023 Q1 | -4.3 Million CNY | -110.99% |
| 2023 Q4 | -119.63 Million CNY | -592.37% |
| 2022 FY | - CNY | -90.01% |
| 2022 Q4 | 39.19 Million CNY | 298.1% |
| 2022 Q3 | -19.78 Million CNY | -146.36% |
| 2022 Q2 | 42.67 Million CNY | -49.87% |
| 2022 Q1 | 85.11 Million CNY | 25.57% |
| 2021 Q1 | 1.67 Billion CNY | 517.11% |
| 2021 Q3 | 250.8 Million CNY | -71.4% |
| 2021 FY | - CNY | -9.72% |
| 2021 Q2 | 876.88 Million CNY | -47.74% |
| 2021 Q4 | 67.78 Million CNY | -72.97% |
| 2020 Q3 | 2.35 Billion CNY | 344.79% |
| 2020 Q2 | 529.79 Million CNY | 538.91% |
| 2020 FY | - CNY | 1149.32% |
| 2020 Q1 | 82.92 Million CNY | 112.32% |
| 2020 Q4 | 271.91 Million CNY | -88.46% |
| 2019 Q4 | -673.05 Million CNY | 0.0% |
| 2019 FY | - CNY | 47.05% |
| 2018 Q2 | 27.87 Million CNY | 0.0% |
| 2018 FY | - CNY | 5.53% |
| 2018 Q1 | 27.87 Million CNY | -18.47% |
| 2017 Q1 | 34.85 Million CNY | 76.56% |
| 2017 Q3 | 34.18 Million CNY | -1.94% |
| 2017 Q4 | 34.18 Million CNY | 0.0% |
| 2017 FY | - CNY | 146.11% |
| 2017 Q2 | 34.85 Million CNY | -0.0% |
| 2016 Q1 | 21.49 Million CNY | -21.48% |
| 2016 FY | - CNY | -17.02% |
| 2016 Q4 | 19.74 Million CNY | 0.0% |
| 2016 Q3 | 19.74 Million CNY | -8.15% |
| 2016 Q2 | 21.49 Million CNY | 0.0% |
| 2015 Q4 | 27.37 Million CNY | 48.53% |
| 2015 Q1 | 24.75 Million CNY | 20.63% |
| 2015 FY | - CNY | 22.74% |
| 2015 Q2 | 24.75 Million CNY | -0.0% |
| 2015 Q3 | 18.42 Million CNY | -25.55% |
| 2014 Q1 | 15.01 Million CNY | 0.0% |
| 2014 Q4 | 20.52 Million CNY | 0.0% |
| 2014 FY | - CNY | 43.89% |
| 2014 Q3 | 20.52 Million CNY | 36.65% |
| 2014 Q2 | 15.01 Million CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 3.15 Billion CNY | 97.254% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 1.05 Billion CNY | 91.758% |
| Blue Sail Medical Co.,Ltd. | 132.74 Million CNY | 34.775% |
| Andon Health Co., Ltd. | 1.69 Billion CNY | 94.901% |
| Allmed Medical Products Co., Ltd | 409.86 Million CNY | 78.876% |
| Improve Medical Instruments Co., Ltd. | 17.73 Million CNY | -388.116% |
| Tofflon Science and Technology Group Co., Ltd. | 826.99 Million CNY | 89.531% |
| Truking Technology Limited | 585.49 Million CNY | 85.212% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 336.13 Million CNY | 74.242% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 357.94 Million CNY | 75.811% |
| Autek China Inc. | 965.74 Million CNY | 91.035% |
| Intco Medical Technology Co., Ltd. | 1.16 Billion CNY | 92.578% |
| Jiangsu Apon Medical Technology Co., Ltd. | 41.9 Million CNY | -106.603% |
| Winner Medical Co., Ltd. | 1.4 Billion CNY | 93.85% |
| Imeik Technology Development Co.,Ltd. | 2.2 Billion CNY | 96.069% |
| Caina Technology Co., Ltd. | 161.95 Million CNY | 46.54% |